Manuel Anja 4

What Happened
Manuel Anja, a director of Hims & Hers Health, Inc. (HIMS), had restricted stock units (RSUs) convert into a total of 13,696 shares of Class A common stock: 3,656 shares on June 11, 2026 and 10,040 shares on June 15, 2026. The conversions are reported as derivative exercises (code M) and show $0.00 per share, indicating these were RSU vesting/conversions rather than cash purchases or open-market sales.

Key Details

• Transaction dates: June 11, 2026 (3,656 shares) and June 15, 2026 (10,040 shares).
• Price per share reported: $0.00 (no cash paid on conversion). Total cash value reported on Form 4: $0.
• Aggregate shares converted: 13,696 shares.
• Shares owned after transaction: not stated in this filing.
• Filing date / report filed: June 15, 2026 (covers transactions through June 15, 2026) — appears timely relative to the reported vesting date.
• Footnotes: F1–F3 confirm these were RSUs that vest into one share per RSU. F2 shows a 3-year service-based vesting schedule (1/3 on 6/15/2025, 1/3 on 6/15/2026, 1/3 on 5/15/2027).

Context
These entries represent RSU vesting and conversion into common stock (an award realization), not open-market buying or selling. Because no sale occurred, this action does not directly signal a market-directional trade; it reflects compensation/vesting under the company’s equity plan.